TP53 and non-small cell lung carcinoma: Alternatively, fusing the tumor suppressor p53 to CD63 in HEK293T-derived EVs enabled delivery to H1299 human non-small cell lung carcinoma cells, resulting in significantly increased intracellular p53 protein levels and enhanced apoptosis [113].